Efficacy and Safety of a New Botulinum Toxin Type A for Treatment of Facial Expression Lines

NCT01180348 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Wrinkles

Interventions

DRUG: Botulift
DRUG: Botox

Sponsor

Azidus Brasil

Collaborators

[object Object]